327 related articles for article (PubMed ID: 23833274)
81. Latent Inflammation and Insulin Resistance in Adipose Tissue.
Stafeev IS; Vorotnikov AV; Ratner EI; Menshikov MY; Parfyonova YV
Int J Endocrinol; 2017; 2017():5076732. PubMed ID: 28912810
[TBL] [Abstract][Full Text] [Related]
82. The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease.
von Loeffelholz C; Roth J; Coldewey SM; Birkenfeld AL
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944668
[TBL] [Abstract][Full Text] [Related]
83. Ectopic lipid metabolism in anterior pituitary dysfunction.
Baumgartner C; Krššák M; Vila G; Krebs M; Wolf P
Front Endocrinol (Lausanne); 2023; 14():1075776. PubMed ID: 36860364
[TBL] [Abstract][Full Text] [Related]
84. The ART of Lowering Ceramides.
Summers SA
Cell Metab; 2015 Aug; 22(2):195-6. PubMed ID: 26244926
[TBL] [Abstract][Full Text] [Related]
85. Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides.
Samuel VT; Shulman GI
N Engl J Med; 2019 Nov; 381(19):1866-1869. PubMed ID: 31693811
[No Abstract] [Full Text] [Related]
86. Characterization and Roles of Membrane Lipids in Fatty Liver Disease.
Welch M; Secunda C; Ghimire N; Martinez I; Mathus A; Patel U; Bhogoju S; Al-Mutairi M; Min K; Lawan A
Membranes (Basel); 2022 Apr; 12(4):. PubMed ID: 35448380
[TBL] [Abstract][Full Text] [Related]
87. Insulin Resistance and Genetic Risk Predict Liver-Related Outcomes and Death in Nonalcoholic Fatty Liver Disease.
Danford CJ; Jiang ZG; Salomaa V; Färkkilä M; Jula A; Männistö S; Lundqvist A; Valsta L; Perola M; Åberg F
Hepatol Commun; 2019 Dec; 3(12):1704-1705. PubMed ID: 31832576
[TBL] [Abstract][Full Text] [Related]
88. What's the role of thymus in diabetes mellitus?
Dai X; Hua L; Chen H; Li Q; Chen W; Liang C
Int Immunopharmacol; 2023 Mar; 116():109765. PubMed ID: 36702074
[TBL] [Abstract][Full Text] [Related]
89. Lowering ceramides to overcome diabetes.
Kusminski CM; Scherer PE
Science; 2019 Jul; 365(6451):319-320. PubMed ID: 31346052
[No Abstract] [Full Text] [Related]
90. Ectopic fat: a target for cardiometabolic risk management.
Gastaldelli A; Gaggini M
Expert Rev Cardiovasc Ther; 2016 Dec; 14(12):1301-1303. PubMed ID: 27817220
[No Abstract] [Full Text] [Related]
91. Defining lipid mediators of insulin resistance - controversies and challenges.
Metcalfe LK; Smith GC; Turner N
J Mol Endocrinol; 2018 Aug; ():. PubMed ID: 30068522
[TBL] [Abstract][Full Text] [Related]
92. Helicobacter pylori and metabolic syndrome-related adipokines in nonalcoholic fatty liver disease pathophysiology.
Kountouras J; Zavos C; Vardaka E; Kyrailidi F; Mouratidou MC; Tzitiridou-Chatzopoulou M; Orovou E; Touloumtzi M; Papanikolaou IS; Kazakos E
J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38725326
[No Abstract] [Full Text] [Related]
93. Unraveling the Paradox of Selective Insulin Resistance in the Liver: the Brain-Liver Connection.
Ferris HA; Kahn CR
Diabetes; 2016 Jun; 65(6):1481-3. PubMed ID: 27222392
[No Abstract] [Full Text] [Related]
94. Insulin resistance: solutions for a common problem.
Lipsky MS; King MS
Hosp Pract (1995); 1999 May; 34(5):120-1. PubMed ID: 10357624
[No Abstract] [Full Text] [Related]
95. Innate Immunity and Inflammation in NAFLD/NASH.
Arrese M; Cabrera D; Kalergis AM; Feldstein AE
Dig Dis Sci; 2016 May; 61(5):1294-303. PubMed ID: 26841783
[TBL] [Abstract][Full Text] [Related]
96. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.
Birkenfeld AL; Shulman GI
Hepatology; 2014 Feb; 59(2):713-23. PubMed ID: 23929732
[TBL] [Abstract][Full Text] [Related]
97. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Buzzetti E; Pinzani M; Tsochatzis EA
Metabolism; 2016 Aug; 65(8):1038-48. PubMed ID: 26823198
[TBL] [Abstract][Full Text] [Related]
98. Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis.
Spahis S; Delvin E; Borys JM; Levy E
Antioxid Redox Signal; 2017 Apr; 26(10):519-541. PubMed ID: 27452109
[TBL] [Abstract][Full Text] [Related]
99. Nonalcoholic fatty liver disease: a systematic review.
Rinella ME
JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
[TBL] [Abstract][Full Text] [Related]
100. Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?
Gruben N; Shiri-Sverdlov R; Koonen DP; Hofker MH
Biochim Biophys Acta; 2014 Nov; 1842(11):2329-2343. PubMed ID: 25128743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
